Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pozzilli

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2011
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosisE Sbardella, V Tomassini, M L Stromillo, et al.
Neurology|September 8, 2010
Safety and efficacy of natalizumab in children with multiple sclerosisA Ghezzi, C Pozzilli, L M E Grimaldi, et al.
AJNR. American Journal of Neuroradiology|September 17, 2021
A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple SclerosisG Pontillo, S Tommasin, R Cuocolo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 17, 2011
Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosisB Goretti, E Portaccio, A Ghezzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2005
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative studyA Ghezzi, M P Amato, M Capobianco, et al.
Neurology|November 14, 2008
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosisD R Altmann, B Jasperse, F Barkhof, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 3, 2007
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term resultsA Ghezzi, M P Amato, M Capobianco, et al.
Neurology|January 5, 2002
The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MSP A Brex, P D Molyneux, P Smiddy, et al.
European Journal of Neurology|March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosisA Novotna, J Mares, S Ratcliffe, et al.
Journal of Neurology|December 6, 2018
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experienceE D'Amico, A Zanghì, M Sciandra, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2011
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosisE Sbardella, V Tomassini, M L Stromillo, et al.
Neurology|September 8, 2010
Safety and efficacy of natalizumab in children with multiple sclerosisA Ghezzi, C Pozzilli, L M E Grimaldi, et al.
AJNR. American Journal of Neuroradiology|September 17, 2021
A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple SclerosisG Pontillo, S Tommasin, R Cuocolo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 17, 2011
Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosisB Goretti, E Portaccio, A Ghezzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2005
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative studyA Ghezzi, M P Amato, M Capobianco, et al.
Neurology|November 14, 2008
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosisD R Altmann, B Jasperse, F Barkhof, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 3, 2007
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term resultsA Ghezzi, M P Amato, M Capobianco, et al.
Neurology|January 5, 2002
The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MSP A Brex, P D Molyneux, P Smiddy, et al.
European Journal of Neurology|March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosisA Novotna, J Mares, S Ratcliffe, et al.
Journal of Neurology|December 6, 2018
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experienceE D'Amico, A Zanghì, M Sciandra, et al.
Pageof 19